Media releases

1 month ago

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

2 months ago

DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer

2 months ago

DemeRx Appoints Michael Snitkovsky as COO

2 months ago

Commissioner’s National Priority Voucher (CNPV) Pilot Program

8 months ago

DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)

10 months ago

In Waves and War: Healing Trauma Through the Science of Neuroplasticity

10 months ago

DemeRx Awarded $1.7 Million National Institutes of Health Grant

1 year ago

DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors

1 year ago

DemeRx Joins Medical Psychedelics Working Group to Advance Next-Generation Addiction Treatments

2 years ago

DemeRx NB Inc. Advances Study for Alcohol Use Disorder Treatment